Search by Drug Name or NDC

    NDC 25021-0107-20 ceftriaxone 2 g/1 Details

    ceftriaxone 2 g/1

    ceftriaxone is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is CEFTRIAXONE SODIUM.

    Product Information

    NDC 25021-0107
    Product ID 25021-107_71bf5ebd-afe1-4906-86ef-76d7e205ec68
    Associated GPIs 02300090102120
    GCN Sequence Number 009164
    GCN Sequence Number Description ceftriaxone sodium VIAL 2 G INJECTION
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 39963
    HICL Sequence Number 003996
    HICL Sequence Number Description CEFTRIAXONE SODIUM
    Brand/Generic Generic
    Proprietary Name ceftriaxone
    Proprietary Name Suffix n/a
    Non-Proprietary Name ceftriaxone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, FOR SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units g/1
    Substance Name CEFTRIAXONE SODIUM
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065329
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0107-20 (25021010720)

    NDC Package Code 25021-107-20
    Billing NDC 25021010720
    Package 25 VIAL in 1 CARTON (25021-107-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
    Marketing Start Date 2009-11-05
    NDC Exclude Flag N
    Pricing Information N/A